Frontiers in Medical Science Research, 2019, 1(4); doi: 10.25236/FMSR.2019.010408.
Yanyan zhu1, Wei tian2, Guanqi gao3, Wenhua du 3*
1 Department of Graduate Office,Shandong First Medical University & Shandong Academy of Medical Sciences, China
2 Emergency Department of Linyi people's Hospital, China
3 Department of Endocrinology, Linyi people's Hospital, China
*Corresponding Author
Bckground. 17α-hydroxylase deficiency is a very rare congenital adrenal hyperplasia, which is caused by the mutation of CYP17A1 gene encoding 17α-hydroxylase. The main clinical features include hypertension and hypokalemia, and false hermaphroditism can also be found in men. Case. A 37-year-old phenotypic female with 17 α-hydroxyenzyme deficiency showed hypertension and hypokalemia. Laboratory tests showed that high levels of progesterone, follicular stimulating hormone, luteinizing hormone, karyotype: 46,XY,CYP17A1 gene exons 8 Asp487-Ser488-Phe489 deletion homozygous mutation, and finally diagnosed as 17 α-hydroxyenzyme deficiency. Conclusion. 17 OHD is a rare disease, which is easy to be missed or misdiagnosed, karyotype analysis and gene sequence analysis are helpful to differential diagnosis and diagnosis.
17α-hydroxyenzyme deficiency; Congenital adrenal cortical hyperplasia; Male pseudohermaphroditism
Yanyan zhu, Wei tian, Guanqi gao, Wenhua du. A case report of male pseudohermaphroditism caused by 17 α-hydroxyenzyme deficiency. Frontiers in Medical Science Research (2019) Vol. 1 Issue 4: 48-51. https://doi.org/10.25236/FMSR.2019.010408.
[1] Soveid MA, Rais -Jalali GA (2016). Seventeen alpha -hydroxylase deficiency associated with absent gonads and myelolipoma: A case report and review of literature. Iran J Med Sci, vol.1, no.6, pp. 543.
[2] Biglieri E G, Herron M A, Brust N (1966). 17-hydroxylation deficiency in man. J Clin Invest, vol. 45, no.12, pp.1946-1954.
[3] Chen Xuefeng, Fu Junfen, Wang Chunlin, et al (2010). A case report of 17a hydroxylase deficiency and literature review. Journal of Southern Medical University, vol.30, no.4, pp. 797-798.
[4] Costa-Santos M, Kater CE, Auchus RJ, et a1 (2004).Two prevalent CYPl7 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17a-hydroxylase deficiency. J Clin Endoerinol Metab,vol.89, no.1, pp.49-60
[5] Fardella CE, Lin HZ, Mahachoklertwattna P (1993). Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450C17 causes severe 17a-hydroxylase deficiency.J Clin Endocrinol Metab, no.77, pp.489-493.
[6] Crumbach MM. Hughes IA. Conte FA. Disorder of sex differentiation. In:Larsen PR, Kronenberg HM, Melmed S, et, al. eds. Willlians Textbook of Endocrinology.10th ED. Phiadelphia: Saunders, 2003,842-1002.
[7] Hu Junping, Yu Yonghao, Bao Yuqian (2013). Congenital adrenocortical hyperplasia (17 α -hydroxylase deficiency): a case report of Chinese Journal of Endocrine Metabolism, vol.8, pp.727-728.
[8] Chinese Medical Association. Guiding principles for clinical application of glucocorticoid drugs. Chinese Journal of Endocrine Metabolism, 2a-1- 2a-32.
[9] Punthakee Z, Legault L (2003). Polychronakos e Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency. J Pediatr, vol. 43, no.3, pp.402-405
[10] Rivkees SA, Crawford JD (2000). Dexamethasone treatment of virilizing congenital adrenal hyperplasia:the ability to achieve normal growth. J Pediatrics, vol.106, no.4, pp.767-773.
[11] Giulia Lanzolla, Giuseppe Vancieri, Silvia Lanciotti, et al (2017). The Glu331del mutation in the CYP17A1 gene causes atypical congenital adrenal hyperplasia in a 46, XX female. Gynecological Endocrinology, vol. 33, no.12, pp.34-35